This study was conducted to estimate the prevalence of NAFLD and liver enzyme abnormalities (ALT, AST, GGT) in a sample of IT professionals and to identify key sociodemographic, behavioral, and metabolic predictors associated with the disease. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.